Alyeska Investment Group
CBIO

Alyeska Investment Group’s Crescent Biopharma CBIO Stock Holding History

Alyeska Investment Group’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.85M Hold
264,000
– – 0.01% 478
2025
Q4 		$3.11M Buy
+264,000
New +$3.36M 0.01% 494
2018
Q4 		– Sell
-4,501
Closed -$6.48M – 411
2018
Q3 		$6.48M Sell
4,501
-90
-2% -$136K 0.07% 220
2018
Q2 		$7.41M Sell
4,591
-279
-6% -$480K 0.07% 242
2018
Q1 		$7.9M Buy
4,870
+3,242
+199% +$6.74M 0.07% 250
2017
Q4 		$2.73M Sell
1,628
-1,962
-55% -$2.59M 0.02% 306
2017
Q3 		$5.02M Buy
3,590
+90
+3% +$106K 0.04% 293
2017
Q2 		$3.91M Buy
+3,500
New +$2.89M 0.03% 299
2015
Q4 		– Sell
-350
Closed -$196K – 414
2015
Q3 		$196K Buy
350
+32
+10% +$23.1K ﹤0.01% 449
2015
Q2 		$253K Buy
318
+5
+2% +$4.14K ﹤0.01% 473
2015
Q1 		$261K Buy
313
+23
+8% +$17.9K ﹤0.01% 483
2014
Q4 		$209K Sell
290
-11
-4% -$8.61K ﹤0.01% 467
2014
Q3 		$209K Sell
301
-4
-1% -$3.24K ﹤0.01% 371
2014
Q2 		$257K Sell
305
-447
-59% -$445K 0.01% 387
2014
Q1 		$1.23M Buy
+752
New +$910K 0.04% 285

Other funds holding CBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM